Deltex Medical Group plc
DTXMF
$0.0952
$0.09223,073.33%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.47% | -6.20% | -63.15% | -65.88% | 19.19% |
| Total Depreciation and Amortization | 3.36% | 6.93% | 46.56% | 49.02% | 5.31% |
| Total Amortization of Deferred Charges | 324.00% | 340.50% | -83.76% | -83.90% | -0.79% |
| Total Other Non-Cash Items | 3,246.15% | 3,541.67% | 41.99% | 44.54% | -96.87% |
| Change in Net Operating Assets | -147.49% | -149.23% | -233.53% | -235.77% | 252.84% |
| Cash from Operations | -43.74% | -48.92% | -2,147.41% | -2,178.97% | 53.40% |
| Capital Expenditure | -- | -- | 86.52% | 86.52% | 86.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.88% | 100.91% | 64.29% | 63.68% | 22.67% |
| Cash from Investing | 100.86% | 100.88% | 65.64% | 65.07% | 31.11% |
| Total Debt Issued | -71.20% | -71.20% | -100.00% | -100.00% | -- |
| Total Debt Repaid | 51.67% | 51.67% | 81.78% | 81.78% | -150.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -77.21% | -76.34% | 700.08% | 713.53% | -84.26% |
| Foreign Exchange rate Adjustments | 256.82% | 262.79% | 788.89% | 805.56% | -238.46% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.96% | -8.73% | 551.82% | 559.47% | -283.12% |
